{{Rsnum
|rsid=4925540
|Gene=ZNF670
|Chromosome=1
|position=247051576
|Orientation=plus
|GMAF=0.2571
|Gene_s=GCNT1P1,ZNF670
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;C)
|geno3=(C;C)
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;C)
| geno3=(C;C)
| CEU | 43.4 | 46.9 | 9.7
| HCB | 99.3 | 0.7 | 0.0
| JPT | 100.0 | 0.0 | 0.0
| YRI | 25.9 | 46.3 | 27.9
| ASW | 35.1 | 49.1 | 15.8
| CHB | 99.3 | 0.7 | 0.0
| CHD | 0.0 | 0.0 | 0.0
| GIH | 61.4 | 32.7 | 5.9
| LWK | 32.7 | 47.3 | 20.0
| MEX | 65.5 | 25.9 | 8.6
| MKK | 38.5 | 50.6 | 10.9
| TSI | 48.0 | 45.1 | 6.9
| HapMapRevision=28
}}{{PMID Auto GWAS
  |PMID=23006423
  |Trait=Response to taxane treatment (docetaxel)
  |Title=Genetic association with overall survival of taxane-treated lung cancer patients - A genome-wide association study in human lymphoblastoid cell lines followed by a clinical association study.
  |RiskAllele=
  |Pval=2E-6
  |OR=NR
  |ORtxt=NR
  |OA=1
}}

{{on chip | Illumina Human 1M}}